Literature DB >> 22811882

Effectiveness of radiation therapy in GIST: A case report.

Joshua Halpern, Yong-June Kim, Rumana Sultana, Gina Villani.   

Abstract

Keywords:  Gastrointestinal stromal tumor (GIST); imatinib mesylate; intensity modulated radiation therapy (IMRT); mesenchymal tumor; radiation therapy

Year:  2012        PMID： 22811882      PMCID： PMC3397651          DOI： 10.3978/j.issn.2078-6891.2011.046

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  30 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].

Authors:  Toshirou Nishida; Takeshi Omori; Shigeyuki Ueshima
Journal:  Gan To Kagaku Ryoho       Date:  2011-05

3.  Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up.

Authors:  Margherita Nannini; Guido Biasco; Maria Caterina Pallotti; Monica Di Battista; Donatella Santini; Paola Paterini; Alessandra Maleddu; Anna Mandrioli; Cristian Lolli; Maristella Saponara; Valerio Di Scioscio; Maurizio Zompatori; Fausto Catena; Pietro Fusaroli; Angelo Paolo Dei Tos; Maria Abbondanza Pantaleo
Journal:  Med Oncol       Date:  2011-01-22       Impact factor: 3.064

4.  Gastrointestinal stromal tumors: thirty years experience of an institution.

Authors:  Simone Arolfo; Paolo Mello Teggia; Mario Nano
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

5.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

Review 6.  Gastrointestinal stromal tumors--a review.

Authors:  H Joensuu; L G Kindblom
Journal:  Acta Orthop Scand Suppl       Date:  2004-04

Review 7.  Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.

Authors:  Burton L Eisenberg; Ian Judson
Journal:  Ann Surg Oncol       Date:  2004-05       Impact factor: 5.344

8.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

9.  KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients.

Authors:  Ketan S Gajiwala; Joe C Wu; James Christensen; Gayatri D Deshmukh; Wade Diehl; Jonathan P DiNitto; Jessie M English; Michael J Greig; You-Ai He; Suzanne L Jacques; Elizabeth A Lunney; Michele McTigue; David Molina; Terri Quenzer; Peter A Wells; Xiu Yu; Yan Zhang; Aihua Zou; Mark R Emmett; Alan G Marshall; Hui-Min Zhang; George D Demetri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

10.  Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal.

Authors:  F Duffaud; S Salas; T Huyn; Jl Deville
Journal:  Clin Exp Gastroenterol       Date:  2010-05-12
View more
  6 in total

1.  MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.

Authors:  Rong Fan; Jie Zhong; Sichang Zheng; Zhengting Wang; Ying Xu; Shuyi Li; Jie Zhou; Fei Yuan
Journal:  Tumour Biol       Date:  2013-12-29

2.  Laparoscopic versus open resection of gastric gastrointestinal stromal tumors.

Authors:  Zhen-Bo Shu; Li-Bo Sun; Jun-Peng Li; Yong-Chao Li; Da-Yong Ding
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

3.  microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway.

Authors:  Rong Fan; Jie Zhong; Sichang Zheng; Zhengting Wang; Ying Xu; Shuyi Li; Jie Zhou; Fei Yuan
Journal:  Clin Exp Med       Date:  2014-04-05       Impact factor: 3.984

4.  Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study.

Authors:  Longhao Li; Xin Yi; Haixia Cui; Xuemei Zhao; Jun Dang; Qingfeng Jiang; Ying Li
Journal:  Front Oncol       Date:  2020-11-23       Impact factor: 6.244

Review 5.  Radiotherapy in the Management of Gastrointestinal Stromal Tumors: A Systematic Review.

Authors:  Haidong Zhang; Tianxiang Jiang; Mingchun Mu; Zhou Zhao; Xiaonan Yin; Zhaolun Cai; Bo Zhang; Yuan Yin
Journal:  Cancers (Basel)       Date:  2022-06-28       Impact factor: 6.575

6.  External beam radiation therapy for locally advanced and metastatic gastrointestinal stromal tumors.

Authors:  John J Cuaron; Karyn A Goodman; Nancy Lee; Abraham J Wu
Journal:  Radiat Oncol       Date:  2013-11-23       Impact factor: 3.481
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.